Skip to content

Analgesic Effect of Electroacupuncture in Postthoracotomy Pain: A Prospective Randomized Trial

Wong et al. · Annals of Thoracic Surgery · 2006

🧪Randomized Clinical Trial👥n=25 participants🏥Moderate Clinical Impact

Evidence Level

MODERATE
72/ 100
Quality
4/5
Sample
2/5
Replication
3/5
🎯

OBJECTIVE

Evaluate the role of electroacupuncture in the control of post-thoracotomy pain in patients with lung cancer

👥

WHO

25 patients with non-small cell lung carcinoma undergoing thoracotomy

⏱️

DURATION

7 postoperative days with two daily 30-minute sessions

📍

POINTS

LI-4 (Hegu), GB-34 (Yanglingquan), GB-36 (Waiqiu), and TE-8 (Sanyangluo) ipsilateral

🔬 Study Design

25participants
randomization

Electroacupuncture

n=13

Acupuncture with 60 Hz electrical stimulation + standard analgesia

Sham acupuncture

n=12

Sham acupuncture with blunt needles + standard analgesia

⏱️ Duration: 7-day follow-up

📊 Results in numbers

0%

Reduction in morphine use on day 2

7.5 ± 5 mg

Morphine used — EA group day 2

15.6 ± 12 mg

Morphine used — sham group day 2

p < 0.05

Statistical significance day 2

Percentage highlights

52%
Reduction in morphine use on day 2

📊 Outcome Comparison

PCA morphine use on day 2 (mg)

Electroacupuncture
7.5
Sham acupuncture
15.6

Visual pain scale on day 5 (0-10)

Electroacupuncture
2.5
Sham acupuncture
4
💬 What does this mean for you?

This study showed that electroacupuncture can significantly reduce the need for opioid medications for pain after thoracic surgery. Patients who received real electroacupuncture required less than half the morphine on the second day after surgery, compared with those who received sham acupuncture.

📝

Article summary

Plain-language narrative summary

Cardiothoracic surgery represents one of the greatest challenges in postoperative pain control in modern medicine. Posterolateral thoracotomy, considered the gold standard for surgical access to the chest during pulmonary resections, is also recognized as one of the most painful incisions in all of surgery. This intense pain not only causes significant discomfort to patients but can also lead to serious respiratory complications when not adequately controlled. Traditionally, narcotics such as morphine have been the basis for the treatment of post-thoracotomy pain, but their intensive use is associated with undesirable side effects, including constipation, nausea, vomiting, and, more seriously, respiratory depression that can compromise pulmonary recovery.

In this context, electroacupuncture emerges as a promising and complementary alternative to traditional pain management. Practiced in China for more than 4,000 years, acupuncture is based on the insertion of fine needles at specific points on the body to rebalance the flow of energy (Qi) along meridians, providing specific therapeutic benefits. Although widely accepted in the East, the Western medical community has demanded rigorous scientific evidence about its efficacy in postoperative pain control.

The study in question was conducted as a randomized, double-blind, placebo-controlled clinical trial at Prince of Wales Hospital in Hong Kong between January 2002 and August 2004. The researchers recruited 27 patients diagnosed with operable non-small cell lung carcinoma whose primary tumors measured 4 centimeters or more in diameter, precluding less invasive video-assisted surgery. All patients underwent anatomical pulmonary resection through thoracotomy by a single thoracic surgeon, ensuring standardization of the surgical technique.

The methodology included randomization of patients into two groups: one receiving real electroacupuncture and another receiving sham acupuncture. Both groups continued the standard treatment with oral analgesics and patient-controlled analgesia with intravenous morphine. The researchers selected specific acupuncture points (LI-4, GB-34, GB-36, and TE-8) on the same side as the surgery, known to influence the chest wall and the upper part of the body. Acupuncture sessions lasted 30 minutes and were performed twice a day during the first seven postoperative days.

To ensure adequate control, the researchers developed an innovative sham acupuncture system using blunt-tipped needles that were pressed at the same points without piercing the skin, connected to a turned-off electrical stimulator. Opaque fixators prevented patients and assessors from identifying which type of needle was being used, maintaining the blinding of the study. In the real electroacupuncture group, after needle insertion, the trained therapists (in the context of the study conducted in Hong Kong) adjusted the intensity of the electrical stimulator until the De-Qi state was reached, characterized by a sensation of heaviness, fullness, and numbness, applying alternating current at 60 Hz for 30 minutes.

The main results demonstrated a significant reduction in patient-controlled morphine use on the second postoperative day. The electroacupuncture group used an average of 7.5 milligrams of morphine, compared with 15.6 milligrams in the control group, representing an approximately 50% reduction in narcotic analgesic consumption. Although the visual pain scales showed a trend toward improvement between the second and sixth postoperative days in the electroacupuncture group, this difference did not reach statistical significance, possibly because of the limited sample size.

A particularly interesting finding was the delayed onset of the effects of electroacupuncture. In the first two days after surgery, there were no significant differences between the groups, with the benefits becoming evident only from the second day onward. The researchers attribute this phenomenon to two possibilities: first, the narcotics used during anesthesia may have saturated opioid-mediated pain inhibitory pathways, temporarily masking the effects of acupuncture; second, the 60 Hz frequency used in the study may activate slower-onset pain control pathways, with cumulative effects that manifest gradually.

The clinical implications of these results are promising for patients and professionals in the field of thoracic surgery. The possibility of significantly reducing narcotic use in the early postoperative period represents an important advance in the quality of care. Less dependence on morphine means a lower risk of side effects such as respiratory depression, which is particularly dangerous in patients with pulmonary function already compromised by thoracic surgery. In addition, the reduction of nausea and constipation can significantly improve patient comfort and accelerate overall recovery.

The safety of the procedure was also demonstrated, with no patient experiencing complications related to acupuncture, such as infections or bleeding. It is important to note that no patient in the control group questioned whether they were receiving real or sham acupuncture, confirming the effectiveness of the blinding method developed by the researchers.

However, the study has important limitations that must be considered. The sample size was small, with only 25 patients completing the protocol, limiting the statistical power to detect smaller differences between groups. The single electrical stimulation frequency (60 Hz) may not be optimal, since previous studies in other surgeries have suggested that different frequencies may have varying efficacies. In addition, follow-up was limited to the first seven postoperative days, providing no information on possible long-term benefits of electroacupuncture.

In conclusion, this pioneering study provides preliminary but encouraging scientific evidence about the role of electroacupuncture in post-thoracotomy pain control. The results suggest that this ancient technique may be a valuable ally in the modern therapeutic arsenal, offering a safe alternative for reducing narcotic dependence in the postoperative period. The authors prudently recommend conducting future studies with larger samples, different stimulation frequencies, and longer follow-up to confirm and refine these promising findings. For patients facing thoracic surgery, this research opens hopeful prospects for more effective pain control with fewer side effects.

Strengths

  • 1Well-controlled double-blind design with innovative sham acupuncture
  • 2Standardized anesthesia and analgesia protocol
  • 3Careful selection of specific acupoints for thoracic pain
  • 4Objective evaluation of PCA morphine consumption
⚠️

Limitations

  • 1Small sample size (only 25 patients)
  • 2Pilot study with limited statistical power
  • 3Fixed, non-optimized electroacupuncture frequency
  • 4Follow-up limited to 7 postoperative days
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Posterolateral thoracotomy ranks among the surgical procedures with the highest postoperative pain intensity, and inadequate control of this pain directly compromises ventilatory mechanics, increases the risk of atelectasis, and prolongs hospital stays in patients who already start with reduced pulmonary reserve due to the resection. In this scenario, any strategy that reduces opioid load without sacrificing analgesia has concrete clinical value. This trial demonstrates that adjuvant electroacupuncture can reduce morphine consumption by approximately 50% on the second postoperative day, which translates into lower risk of respiratory depression, less nausea, and better adherence to early respiratory physical therapy. The finding is especially relevant for thoracic surgery centers treating oncologic patients with prior pulmonary functional impairment, where every milligram of opioid spared represents an additional margin of respiratory safety. The technique fits naturally into multimodal postoperative analgesia protocols.

Notable Findings

The most striking data point is the reduction of 7.5 mg versus 15.6 mg of PCA morphine on the second postoperative day, a statistically significant difference in a small sample, suggesting a clinically relevant effect magnitude. Equally intriguing is the temporal pattern of the response: the first two postoperative days showed no difference between groups, with benefit emerging from the second day onward. This points to action kinetics distinct from those of opioids — probably reflecting competitive saturation of opioid-dependent pathways by the anesthetics used intraoperatively, or the slower recruitment profile of descending inhibitory pathways activated by the 60 Hz frequency. This delayed onset is not necessarily a limitation; from a neurophysiological standpoint, it suggests that electroacupuncture acts through mechanisms complementary to conventional opioid analgesia, reinforcing the rationale of multimodal analgesia rather than substitution.

From My Experience

In my practice in postoperative pain and thoracic rehabilitation, I have followed patients referred to the service after ICU discharge with established post-thoracotomy pain syndrome, and the pattern I observe is consistent with what this study anticipates: those who received better pain control in the immediate postoperative period reach rehabilitation with less established central sensitization. I usually start electroacupuncture in the postoperative context as soon as the patient tolerates lateral decubitus and has stabilized venous access, generally between the second and third days, which coincides exactly with the window in which this study demonstrated benefit. I work with frequencies alternating between 2 Hz and 100 Hz in dense-disperse modes, a choice that pain neurophysiology literature supports for broader recruitment of endogenous neuropeptides. I always combine this with morning respiratory physical therapy, since the analgesia provided facilitates active thoracic expansion. The patient profile that responds best, in my observation, is one without prior chronic opioid use, which keeps descending inhibitory pathways more responsive to acupuncture stimulation.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

Annals of Thoracic Surgery · 2006

DOI: 10.1016/j.athoracsur.2005.12.064

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.